Table 2.
Patient’s characteristics between temporary the HD and maintenance HD groups.
| Temporary HD (n = 6) | Maintenance HD (n = 7) | p Value | |
|---|---|---|---|
| Sex (Male/Female) | 1/5 | 5/2 | 0.048 |
| Age (years) | 72.7 ± 18.4 | 65.7 ± 7.8 | 0.381 |
| Classifications of RPGN | |||
| Immune complex CGN | 0 (0%) | 1 (14.3%) | |
| Pauci-immune CGN | 6 (100%) | 2 (28.6%) | |
| Anti-GBM CGN | 0 (0%) | 4 (57.1%) | |
| Immunosuppressive therapy | |||
| Pulse corticosteroids | 6/0 | 6/1 | 0.538 |
| Cyclophosphamide | 1/5 | 0/7 | 0.462 |
| Plasma exchange | 6/0 | 3/4 | 0.049 |
| White blood cell count (103/μL) | 12.6 ± 5.1 | 7.6 ± 2.9 | 0.048 |
| Neutrophil count (103/μL) | 11.0 ± 5.0 | 5.3 ± 2.1 | 0.018 |
| Lymphocyte count (103/μL) | 1.10 ± 0.58 | 1.31 ± 0.43 | 0.470 |
| Platelet count (103/μL) | 289.7 ± 112.7 | 191.4 ± 55.6 | 0.066 |
| CRP (mg/dL) | 11.2 ± 7.0 | 8.1 ± 10.3 | 0.554 |
| ESR (mm/h) | 104 ± 32 | 103 ± 27 | 0.985 |
| MPO-ANCA (U/mL) | 160 (17.0–469.0) | 0 (0–2440) | 0.138 |
| anti-GBM antibody (U/mL) | 0 (0–0) | 42.3 (0–858.0) | 0.065 |
| NLR | 12.4 (4.1–21.4) | 3.9 (2.8–8.4) | 0.008 |
| PLR | 341.7 ± 217.7 | 156.1 ± 62.6 | 0.053 |
Data are presented as the mean ± standard deviation, median (range), or number (%). HD—hemodialysis; RPGN—rapidly progressing glomerulonephritis; CGN—crescentic glomerulonephritis; eGFR—estimated glomerular filtration rate; CRP—C-reactive protein; ESR—erythrocyte sedimentation rate; MPO—myeloperoxidase; ANCA—anti-neutrophil cytoplasmic antibody; PR3—proteinase 3; GBM—glomerular basement membrane; NLR—neutrophil-to-lymphocyte ratio; PLR—platelet-to-lymphocyte ratio.